Pacira BioSciences, Inc.

82P.F·Frankfurt·Healthcare
Compare
32.20+0.20 (+0.63%)today
As of Oct 19, 8:41 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close32.00
Open32.20
Day range—
52-week range15.4032.20
Off day high0.00%
Off 52-week high0.00%
Volume370
Avg. volume (3M)0.00
Market cap1.29B
EPS (TTM)0.3000
Forward P/E8.24
P/E ratio (TTM)107.33
Dividend yield—
Beta (5Y)0.25
Shares outstanding39.91M
Short interest—
Earnings dateAug 4, 2026
Analyst target—
Profit margin1.96%

Against its peers

Compare in full ›
82P.F COLL ALVO AQST AMPH SUPN
Market cap 1.29B 754.96M 1.78B 474.43M 1.10B 2.21B
P/E (TTM) 107.3 18.3 — — 15.3 —
Forward P/E 8.2 3.2 21.9 -6.6 8.1 8.8
Price/book 2.1 2.4 -9.3 -8.4 1.4 2.1
Dividend yield — — — — — —
1-year change +64.10% −33.46% −41.79% −49.53% +9.02% −26.57%
Today +0.63% +0.04% −5.84% −6.90% −2.08% −4.27%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company Mkt cap Price Today
Cronos Group Inc.CRON · Stayner, ON 1.18B 3.2100 +0.31%
Eton Pharmaceuticals, Inc.ETON · Deer Park, IL 1.44B 50.31 −1.99%
Amphastar Pharmaceuticals, Inc.AMPH · Rancho Cucamonga, CA 1.10B 25.87 −2.08%
Knight Therapeutics Inc.GUD.TO · Montreal, QC 1.08B 11.04 +2.22%
Phibro Animal Health CorporationPAHC · Teaneck, NJ 1.58B 38.82 +2.21%
Harrow, Inc.HROW · Nashville, TN 1.02B 27.28 −5.11%
ANI Pharmaceuticals, Inc.ANIP · Baudette, MN 1.66B 72.29 +0.01%
AlvotechALVO · Luxembourg, Luxembourg 1.78B 5.0000 −5.84%

Also based in Brisbane, California, then elsewhere in California.

Company Mkt cap Price Today
CareDx, Inc.CDNA · Brisbane, CA 3.31B 64.00 −4.01%
Nurix Therapeutics, Inc.NRIX · Brisbane, CA 2.67B 24.42 −2.12%
Vera Therapeutics, Inc.VERA · Brisbane, CA 2.01B 27.88 −2.42%
Freenome, Inc.FRNM · Brisbane, CA 1.26B 11.75 −4.35%
Annexon, Inc.ANNX · Brisbane, CA 646.46M 3.4100 −5.28%
Tempest Therapeutics, Inc.TPST · Brisbane, CA 10.54M 0.6242 −1.70%
Meta Platforms, Inc.META · Menlo Park, CAOdds 1.81T 709.33 −3.72%
Broadcom Inc.AVGO · Palo Alto, CAOdds 1.57T 328.75 −4.52%

Companies that serve the same markets: healthcare.

Company Mkt cap Price Today
AlvotechALVO.IC · healthcare 219.80B 616.00 −4.05%
Bioventus Inc.BVS · healthcare 908.46M 13.30 −3.69%
Clover Health Investments, Corp.CLOV · healthcare 2.38B 4.4800 −4.27%
Brookdale Senior Living Inc.BKD · healthcare 2.41B 10.09 0.00%
CareDx, Inc.CDNA · healthcare 3.31B 64.00 −4.01%
iRhythm Holdings, Inc.IRTC · healthcare 3.58B 108.66 −0.63%
Envista Holdings CorporationNVST · healthcare 3.68B 22.90 −2.55%
LivaNova PLCLIVN · healthcare 4.26B 77.58 −1.17%

What visitors to Pacira BioSciences's page also look at.

Company Mkt cap Price Today
Sumitomo Pharma Co. Ltd.DPM.F 4.63B 10.32 +0.66%
China Medical System Holdings R2M7C.F 2.75B 1.1300 0.00%
DR REDDY'S LABORATORIES LTD.RDDA.F 9.58B 11.50 +1.77%
Hikma Pharmaceuticals PLCH5P.F 4.05B 19.57 +0.62%
SHIONOGI & CO. LTD.SH0.F 13.39B 15.74 +0.22%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All 82P.F news ›
Stock Titan·Negative

Pacira BioSciences: DOMA reports 0% ownership

Seven investors report stakes below 5% in Pacira BioSciences (PCRX). Stock Titan - [SCHEDULE 13D/A] Pacira BioSciences, Inc. Amended Major Shareholder Report Pacira BioSciences: DOMA reports 0% ownership The ownership-percentage…

Markets Daily·Positive

Pacira BioSciences (NASDAQ:PCRX) Upgraded at JPMorgan Chase & Co.

Posted by Michael Walen on Oct 11th, 2026 JPMorgan Chase & Co. upgraded shares of Pacira BioSciences (NASDAQ:PCRX – Free Report) from an underweight rating to a neutral rating in a report issued on Thursday,Benzinga reports. The firm…

Seeking Alpha·

Viatris To Acquire Pacira BioSciences: What Investors Should Know

Viatris To Acquire Pacira BioSciences - What Investors Should Know (NASDAQ:VTRS) Seeking Alpha - Viatris is acquiring Pacira BioSciences for $1.65bn to boost its pain management portfolio and address revenue stagnation. - VTRS expects the…

From articles in the 4Search news index.

In the news

41mentions in 30 days
41with it in the headline
Mixedsentiment

Mentioned with

Pacira Biosciences, Inc.34Exparel31Pacira Biosciences, Inc29Eli Lilly24Viatris Inc.23Peach Purchaser Sub Inc.21Pfizer19Acquire Pacira Biosciences16

People in the coverage

Pacira38Viatris37Michael Walen25Benzinga24Daniel Clark22Danessa Lincoln18

Themes

Healthcare36Pcrx33SEC Filings31Vtrs31Viatris15Biotech and Pharma Stock News14Biotech13Deals13

Most coverage from

  1. marketscreener.com9
  2. stocktitan.net5
  3. themarketsdaily.com4
  4. defenseworld.net3
  5. prnewswire.com3

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 41 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.